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LETTERS TO THE EDITOR
BLOOD LEVELS OF 5-FLUOROURACIL DURING
INTRAVENOUS INFUSION
SIR,-Several clinical studies agree that
intravenous infusion of 5-fluorouracil (5FU)
over a period of five days is less toxic than
bolus intravenous injections of drug daily
for five days (Moertel et al., 1972; Seifert et
al., 1975), although there is disagreement
about the frequency of response of gastro-
intestinal tumours so treated (Moertel et
al., 1972; Moertel and Reitemeier, 1969).
Blood levels measured after oral and intra-
venous administration of 5FU have shown
the former to be unpredictable, but in the
latter case the drug has constant kinetics
with a half-life in plasma of 10 min (Cohen et
al., 1974). Measurements of 5FU levels
during infusion of the drug have not been
reported.
We have recently described a new sensi-
tive assay method for measuring 5FU in
plasma by extracting the drug from plasma
using a novel procedure followed by gas
chromatography and mass spectrometry,
with a sensitivity down to approximately
8 x 10-8 M or 10 ng/ml (Hillcoat et al.,
1975). Using this method, plasma levels
of 5FU have been determined in six patients
with malignant disease ofthe gastrointestinal
tract receiving 5FU at 30 mg/kg/day/litre
of 5% dextrose, by gravity infusion. One
patient, J.H., had the infusion repeated
three months later. The results are shown
in the Table. Most patients showed fluctuat-
ing levels often of a considerable degree.
Patient G.A. on three occasions had high
levels with a peak value of 2-4 times the
average peak value found. This patient
showed only minor marrow toxicity (the
nadir of peripheral granulocyte count was
67% of pretreatment levels) and mild
stomatitis. Patient J.B., on the other hand,
had a nadir of 43% but showed lower blood
levels, although higher than those in the
remaining patients. Thus, blood levels of
5FU did not relate to toxicity in this small
series. Only patient G.A., with the highest
and most sustained blood levels, had a
clinical response to treatment. Patient J.H.,
on his second infusion, showed very similar
blood levels of 5FU to those observed
during his first infusion.
The rate of infusion may have played a
role in the marked variation in drug levels
observed (up to 80 fold) and may result
from inability to maintain constant flow
rates by this method. Proper administra-
tion of this drug may require infusion by
TABLE.-Plasma Levels of 5-fluorouractl in Patients Treated by Infusion
of Drugfor 5 Days
G.A.
Day Time' 5FU2
1 1 0
J.B. J.H. 13 J.H. 24
Time 5FU Time 5FU Time 5FU
8 200
13 28
18 342 24 370 18 94
25 20
42 361 48 470 42 44
49 42
66 887 72 83 66 214
4 90 143
5 114 365 116 53
32 80 41 59 40 142 26 42
48 5 47 93 44 <5
56 85 64 49 50 0
63 108 72 88 71 23 68 35
73 150 80 43 89 99 88 494 74 328
90 28 87 158 93 95 96 232 92 53
104 82 113 119 112 81 98
120 68 111 133 117 54 120 0 116
122
1Hours; 2 ng/ml (100 ng/ml = 7
- 7 x 10-7 M); 3 Feb. 5; 4 May 3.
2
3
E.C.
Time 5FU
1 16
17 5
24 36
B.A.
Time 5FU
3 30
16 66
23 88
A.T.
Time 5FU
2 107
20 0
136
403
120
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peristaltic pump to sustain blood levels.
Further studies ofthis type are indicated,
especially to relate blood levels to toxicity
and to clinical response.
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IMPLICATIONS OF THE OSMOLALITIES OF SOME COMMONLY
USED TISSUE CULTURE MEDIA
SIR,-The culture of human tumour cells
in vitro is an essential prerequisite to the
better understanding of tumour biology.
Such cultures are needed for studies of the
mechanisms of specific tumour immunity
and the effectiveness of various chemo-
therapeutic agents. However, the univers-
ally poor results reported of attempts to
culture human tumours in vitro lead one to
conclude that the standard tissue culture
media (originally devised for animal-normal
rodent-tumours) might not be suitable for
the long term culture of human tumour
cells.
As part ofa study ofthe possible variables
affecting the growth of human tumour
cells invitro, the osmolalities of various tissue
culture media have been determined and
the influence of varying the osmolality of
the medium on the growth of human tumour
cells has been studied.
Single strength media obtained com-
mercially (Gibco-Biocult, Paisley or Flow
Laboratories, Irvine) were used for osmolality
determinations. Osmolalities were measured
on a Model 65-31 Osmometer (Advanced
Instruments Inc., Massachusetts, U.S.A.).
All osmolalities were determined at least
twice on separate occasions and in 2 cases
have been confirmed by the manufacturer.
Thirteen of the more commonly used
tissue culture media have been tested both
with and without the addition of 20%
foetal calf serum, and the results are shown
in the Table. Two separate batches were
tested of 5 of the media. In 3 instances
one batch was hypotonic and the other was
hypertonic. Both batches of the other two
media were hypertonic. In addition, all
but 2 (Hams FIO and Diploid growth
medium) of the media tested only once
were hypertonic for human cells. The high
percentage of hypertonic media found here
is disturbing because study of the growth of
tumour cells in primary culture indicates that
theygrowless wellinhypertonic medium than
in hypotonic medium (unpublished results).
The osmolalities of most of the media are
nearer to that of rodent sera than to human
serum. The fact that foetal calf serum is
hypertonic for human cells should also be
considered.
The variation between different batches
of the same medium (e.g. M 199, RPMI 1640